|
ARV-766
|
4-(4-((1-(4-((反式-3-(4-氰基-3-甲氧基苯氧基)-2,2,4,4-四甲基環(huán)丁基)氨基甲Chemicalbook酰基)苯基)哌啶-4-基)甲基)哌嗪-1-基)-N-((S)-2,6-二氧代嘧啶-3-基)-2-氟苯甲酰胺
|
2750830-09-0
|
|
SD49-7
|
2-羥基-1-萘甲醛水楊酰腙
|
54009-54-0
|
|
BMS-191011
|
3-(5-氯-2-羥基芐基)-5-(4-(三氟甲基)苯基)-1,3,4-惡二唑-2(3H)-酮
|
202821-81-6
|
|
PF-3845
|
PF 3845
|
1196109-52-0
|
|
WAY-312778
|
化合物WAY-312778
|
301157-29-9
|
|
UPGL00004
|
UPGL00004
|
1890169-95-5
|
|
RS 100329 HCL
|
化合物 T23253
|
1215654-26-4
|
|
LeterMovir-008-R
|
萊特莫韋雜質
|
917389-34-5
|
|
LeterMovir-013
|
萊特莫韋雜質
|
917389-37-8
|
|
Olaparib Impurity
|
奧拉帕尼雜質
|
2415448-60-9
|
|
(Rac)-Brassinazole
|
3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇
|
224047-41-0
|
|
Givinostat (ITF2357)
|
N-[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯鹽酸鹽
|
732302-99-7
|
|
3 - Hydroxy - 5 - n - pentyl - 2 - cyclohexen - 1 - on
|
3-羥基-5-戊基環(huán)己-2-烯-1-酮
|
58016-29-8
|
|
PDGFR Tyrosine Kinase Inhibitor III
|
PDGFR酪氨酸激酶抑制劑III
|
205254-94-0
|
|
BYK 191023 dihydrochloride
|
BYK191023二鹽酸鹽
|
1216722-25-6
|
|
RP70676
|
RP70676
|
136609-26-2
|
|
MMRi62
|
7-((2,3-二氯苯基)(吡啶-2-基氨基)甲基)喹啉-8-醇
|
352693-80-2
|
|
dTRIM24
|
dTRIM24
|
2170695-14-2
|
|
RAD51-IN-17
|
RAD51-IN-17
|
2101739-18-6
|
|
GRP-60367
|
(4-((2-(2,5-二甲基苯氧基)乙基)氨基)哌啶-1-基)(吡啶-4-基)甲酮
|
1309241-34-6
|
|
HIF-1 inhibitor-4
|
WAY-299838
|
333357-56-5
|
|
CP-289503
|
化合物CP-289
|
1349637-14-4
|
|
GR 125,743
|
化合物GR 125743
|
148547-33-5
|
|
CK1-IN-1
|
CK1-IN-1
|
1784751-20-7
|
|
ALW-II-49-7
|
化合物 ALW-II-49-7
|
1135219-23-6
|
|
TH-Z93
|
化合物TH-Z93
|
2260887-09-8
|
|
917389-35-6
|
來特莫韋雜質
|
917389-35-6
|
|
AMG487
|
AMG 487
|
473719-41-4
|
|
MPT0B014
|
B014
|
1215208-59-5
|
|
3PO
|
(E)-3-吡啶-3-基-1-吡啶-4-基 - 丙烯酮;
|
18550-98-6
|
|
p38α inhibitor 3
|
WAY-313218
|
260428-69-1
|
|
JNJ-18038683
|
化合物JNJ-18038683
|
851376-05-1
|
|
KA2507
|
產(chǎn)品Benzamide
|
1636894-46-6
|
|
Imiquimod Impurity
|
咪喹莫特雜質
|
99010-41-0
|
|
BRD4 Inhibitor-20
|
化合物 BRD4 INHIBITOR-20
|
2490311-14-1
|
|
Tazanolast
|
他扎司特
|
82989-25-1
|
|
Ro0335
|
RO0335
|
867365-76-2
|
|
Benzo[b]thien-2-yl Ketone
|
絲裂霉素雜質
|
97978-07-9
|
|
Letermovir Impurity
|
1,3-雙(2-甲氧基-5-(三氟甲基)苯基)脲
|
6064-14-8
|
|
CA-4948
|
CA-4948
|
1801343-74-7
|
|
ZINC05007751
|
ZINC05007751
|
591239-68-8
|
|
LUN76721
|
4376-72-1游離
|
4376-72-1
|
|
MLN120B.2 HCl
|
MLN120B DIHYDROCHLORIDE
|
1782573-78-7
|
|
CITCO
|
CITCO
|
338404-52-7
|
|
BMS-P5
|
BMS-P5
|
1550371-22-6
|
|
AM1241
|
(2-碘-5-硝基苯基)(1-((1-甲基哌啶-2-基)甲基)-1H-吲哚-3-基)甲酮
|
444912-48-5
|
|
Finasteride Carboxaldehyde
|
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-二甲基-2-氧代乙基)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-十四氫-4a,6a-二甲基-2-氧代-1H-茚并[5,4-f]喹啉-7-羧酰胺
|
154387-61-8
|
|
2-(2,6-dichloro-3,5-dimethoxyphenyl)acetonitrile
|
2-(2,6-二氯-3,5-二甲氧基苯基)乙腈
|
869882-16-6
|
|
ML148
|
piperidin-1-yl(1-m-tolyl-1H-indazol-6-yl)methanone
|
451496-96-1
|
|
TUG-469
|
TUG-469
|
1236109-67-3
|
|
VH032
|
VH-032
|
1448188-62-2
|
|
TH34
|
CS-2858
|
2196203-96-8
|
|
PF-02545920
|
PF-02545920
|
898563-49-0
|
|
Aumitin
|
AUMITIN
|
946293-78-3
|
|
TD-106
|
TD-106
|
2250288-69-6
|
|
5,6,7,8-TETRAHYDRO-4 H-CYCLOHEPTA[ D ]ISOXAZOLE-3-CARBOXYLIC ACID
|
:4H,5H,6H,7H,8H-環(huán)庚烷[D][1,2]噁唑-3-羧酸;5,6,7,8-TETRAHYDRO-4 H-CYCLOHEPTA[ D ]ISOXAZOLE-3-CARBOXYLIC ACID
|
33230-32-9
|
|
HCV-IN-31
|
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)-
|
1998705-62-6
|
|
SERALUTINIB
|
3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-
|
1619931-27-9
|
|
SG-094
|
SG094
|
2922283-37-0
|
|
WAY-661957
|
化合物WAY-661957
|
899902-32-0
|
|
Nampt activator-1
|
化合物 NAMPT ACTIVATOR-1
|
701929-65-9
|
|
PHT-427
|
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺
|
1191951-57-1
|
|
C3a receptor agonist 1
|
2-環(huán)己基-2-苯基-N-[1-(3-吡啶-3-基丙?；?哌啶-4-基]乙酰胺
|
944997-60-8
|
|
RS 100329
|
5-甲基-3-[3-[3-[4-[2-(2,2,2-三氟乙氧基)苯基]-1-哌嗪基]丙基]-2,4-(1H,3H)-嘧啶酮] 鹽酸鹽
|
232953-52-5
|
|
Gsk484 hydrochloride
|
CS-2265
|
1652591-81-5
|
|
LRE1
|
化合物 T15787
|
1252362-53-0
|
|
THAL-SNS-032
|
THAL-SNS-032
|
2139287-33-3
|
|
Vodobatinib
|
K0706
|
1388803-90-4
|
|
TT01001
|
1-Piperidinecarboxylic acid, 4-[[[(3,5-dichlorophenyl)amino]thioxomethyl]amino]-, ethyl ester
|
1022367-69-6
|
|
LP-471756
|
化合物 T27850
|
413605-11-5
|
|
Acitazanolast
|
阿扎司特
|
114607-46-4
|
|
DC-TEADin02
|
化合物DC-TEADIN02
|
2380228-45-3
|
|
CP-447697
|
4-[(苯并[B]噻吩-3-基羰基)[2-(4-氯苯基)乙基]氨基]-N-(2,4-二氟苯基)-1-哌啶甲酰胺
|
1092847-21-6
|
|
NLRP3-IN-10
|
化合物 NLRP3-IN-10
|
2641826-39-1
|
|
BI-2865
|
(4S)-2-氨基-4,5,6,7-四氫-4-甲基-4-[3-[4-[(1S)-1-[(2S)-1-甲基-2-吡咯烷基]乙氧基]-2-嘧啶基]-1,2,4-惡二唑-5-基]苯并[b]噻吩-3-甲腈
|
2937327-93-8
|
|
Laninamivir
|
拉尼米韋
|
203120-17-6
|
|
MG149
|
MG149
|
1243583-85-8
|
|
Rhosin
|
(R,E)-2-氨基-3-(1H-吲哚-3-基)-N'-(喹喔啉-6-基亞甲基)丙酰肼
|
1281870-42-5
|
|
Todralazine hydrochloride
|
鹽酸托屈嗪
|
3778-76-5
|
|
Benzenepropanoicacid
|
3,5-二(叔丁基)-4-羥基-苯丙酸,3-羥基-2,2-雙(羥甲基)丙酯
|
26347-98-8
|
|
hMAO-B-IN-4
|
化合物HMAO-B-IN-4
|
1666119-75-0
|
|
ROCK-IN-5
|
2-(2-氯-6-氟苯基)-N-(4-(吡啶-4-基)噻唑-2-基)乙酰胺
|
692870-25-0
|
|
DBRD9
|
DBRD9
|
2170679-45-3
|
|
GSK215
|
GSK215
|
2743427-26-9
|
|
APY0201
|
化合物APY0201
|
1232221-74-7
|
|
pipequaline.HCl
|
鹽酸哌夸林
|
80221-58-5
|
|
F-15599
|
635323-95-4
|
635323-95-4
|
|
ASTX660
|
ASTX660
|
1799328-86-1
|
|
Buspirone Impurity
|
丁螺環(huán)酮雜質
|
2726492-72-2
|
|
CCR8 antagonist 1
|
化合物CCR8 ANTAGONIST 1
|
723304-76-5
|
|
2(1H)-Pyridinone,4-hydroxy-5-methyl-(9CI)
|
非奈利酮雜質
|
41935-71-1
|
|
Merafloxacin
|
CI 934
|
91188-00-0
|
|
Sapropterin Hydrochloride
|
(6R)-5,6,7,8-四氫生物蝶呤二鹽酸鹽
|
69056-38-8
|
|
TC-DAPK 6
|
2-(2-苯乙烯基)-4-(3-吡啶基亞甲基)-5(4H)-惡唑酮
|
315694-89-4
|
|
MLN120B
|
N-(6-氯-7-甲氧基-9H-吡啶并[3,4-B]吲哚-8-基)-2-甲基-3-吡啶甲酰胺
|
783348-36-7
|
|
RG 14620
|
TYRPHOSTIN RG 14620
|
136831-49-7
|
|
RN-18
|
431980-38-0
|
431980-38-0
|
|
MS402
|
MS-402
|
1672684-68-2
|
|
VB-124
|
VB-124
|
2230186-18-0
|
|
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-(1-methylethyl) 5-[(1-oxobutoxy)methyl] ester
|
2177293-82-0游離態(tài)
|
2177293-82-0
|